GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Stoke Therapeutics STOK · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.71

+4.41%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Stoke Therapeutics

Our reporting

Next results

15 Mar 2027

Due on 15 Mar 2027. Analysts expect earnings of -1.10 a share on revenue of $8.8m.

Past results

Reported against what analysts expected

29 Oct 20263 Aug 20267 May 202616 Mar 20264 Nov 202512 Aug 2025
Earnings per share-1.08-0.93-0.79-0.97-0.65-0.40
Forecast-0.93-0.80-0.80-0.75-0.54-0.57
Revenue$11.3m$9.3m$6.2m$1.4m$10.6m$13.8m
Forecast$8.2m$4.9m$6.5m$5.8m$4.6m$5.4m

Key events

  1. 19 Jun 2019Listed

Stoke Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.